UNSPSC 51281519: Delamanid

Delamanid (USAN, INN) is a drug for the treatment of multi-drug-resistant tuberculosis. It works by blocking the synthesis of mycolic acids in Mycobacterium tuberculosis, the organism which causes tuberculosis, thus destabilising its cell wall. The drug is approved in the EU under the trade name Deltyba (made by Otsuka Pharmaceutical).

UNSPSC 51281519 Delamanid, a Commodity code, does not match the work actually being solicited under recent state and local opportunities tagged to it. The code nominally refers to delamanid, a tuberculosis drug; however, the recent solicitations show state and local governments procuring naloxone (opioid overdose reversal), medical and first aid supplies for emergency response, generic multi-source pharmaceuticals and OTC products through cooperative purchasing, and direct-to-manufacturer prescription fulfillment capabilities. None of these categories align with delamanid specifically, indicating a tagging mismatch between the code assignment and the actual procurement activity. The opportunities span health departments, city fire rescue divisions, multi-state cooperative purchasing alliances, and state HHS commissions—a broad issuing-body mix—but the code itself shows no relevant recent activity.

Geographic activity centers on Florida (Seminole County's naloxone and drug deactivation systems IFB, posted June 30, 2026, due July 26, 2023), Texas (Texas HHS Commission's RFI for direct-to-manufacturer prescriptions, posted April 3, 2026), Florida (City of Tampa Fire Department medical supplies IFB 26P00145, posted March 25, 2026, due March 13, 2026, with an estimated $700,000 contract value and SLBE set-aside), and a multi-state cooperative purchasing vehicle (Minnesota MMCAP's RFP S1070000015802 for generic pharmaceuticals and OTC products, posted January 20, 2026, due March 26, 2026, serving Minnesota and Oregon). The code shows little relevant recent activity and does not serve as a reliable indicator of state and local procurement for delamanid or closely related pharmaceutical products.